Page last updated: 2024-09-04

cryptotanshinone and Endotoxin Shock

cryptotanshinone has been researched along with Endotoxin Shock in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, Z; Hou, X; Li, R; Liu, H; Qin, Q; Shi, W; Wang, J; Wang, Y; Wang, Z; Xiao, X; Xu, G; Yang, R; Zhan, X	1

Other Studies

1 other study(ies) available for cryptotanshinone and Endotoxin Shock

Article	Year
Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacological research, 2021, Volume: 164 Topics: Animals; Cells, Cultured; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Liver; Macrophages; Male; Mice, Inbred C57BL; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Phenanthrenes; Reactive Oxygen Species; Shock, Septic; T-Lymphocytes, Regulatory; Th17 Cells; Tumor Necrosis Factor-alpha	2021

Article

Year

Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases.

Pharmacological research, 2021, Volume: 164

Topics: Animals; Cells, Cultured; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Liver; Macrophages; Male; Mice, Inbred C57BL; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Phenanthrenes; Reactive Oxygen Species; Shock, Septic; T-Lymphocytes, Regulatory; Th17 Cells; Tumor Necrosis Factor-alpha

2021